US · Healthcare

Autolus Therapeutics Ltd (AUTL)

Biotechnology

Autolus Therapeutics Ltd (AUTL) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for AUTL

P/E ratio

18.00

Autolus Therapeutics Ltd (AUTL) — FAQ

What is AUTL's P/E ratio?

The price-to-earnings (P/E) ratio for Autolus Therapeutics Ltd (AUTL) is 18.00 (data as of 2026-03-23).

Does Autolus Therapeutics Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Autolus Therapeutics Ltd (AUTL). Check the MyAverix Finance app for the latest dividend data.

What sector is Autolus Therapeutics Ltd in?

Autolus Therapeutics Ltd (AUTL) is classified in the Healthcare sector (Biotechnology industry).

What exchange is AUTL listed on?

AUTL is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)